Gevo (GEVO) to Release Quarterly Earnings on Thursday

Gevo (NASDAQ:GEVO) is expected to be announcing its Q4 2025 results after the market closes on Thursday, March 5th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $43.5160 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, March 5, 2026 at 4:30 PM ET.

Gevo Stock Up 4.4%

GEVO stock opened at $1.90 on Tuesday. The business’s 50-day moving average price is $1.96 and its 200-day moving average price is $2.03. The stock has a market cap of $460.39 million, a P/E ratio of -9.50 and a beta of 1.51. The company has a quick ratio of 1.60, a current ratio of 1.91 and a debt-to-equity ratio of 0.29. Gevo has a twelve month low of $0.92 and a twelve month high of $2.95.

Analyst Ratings Changes

GEVO has been the subject of a number of recent analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Gevo in a research report on Thursday, January 22nd. Northland Securities reaffirmed an “outperform” rating and issued a $3.00 target price on shares of Gevo in a report on Wednesday, December 31st. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Gevo presently has a consensus rating of “Hold” and a consensus price target of $6.42.

Insider Transactions at Gevo

In other news, CFO Oluwagbemileke Yusuf Agiri sold 73,284 shares of Gevo stock in a transaction that occurred on Friday, December 5th. The stock was sold at an average price of $2.31, for a total value of $169,286.04. Following the completion of the transaction, the chief financial officer owned 271,224 shares in the company, valued at approximately $626,527.44. The trade was a 21.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 85,844 shares of company stock worth $196,125 in the last quarter. Corporate insiders own 4.00% of the company’s stock.

Institutional Trading of Gevo

A number of large investors have recently made changes to their positions in GEVO. Franklin Resources Inc. purchased a new position in Gevo during the 4th quarter worth $28,000. Mackenzie Financial Corp purchased a new position in shares of Gevo during the third quarter valued at $29,000. Cibc World Markets Corp bought a new stake in shares of Gevo in the fourth quarter valued at about $31,000. Balyasny Asset Management L.P. bought a new stake in shares of Gevo in the fourth quarter valued at about $35,000. Finally, Abel Hall LLC purchased a new stake in Gevo in the fourth quarter worth about $36,000. 35.17% of the stock is owned by hedge funds and other institutional investors.

Gevo Company Profile

Gevo, Inc (NASDAQ: GEVO) is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company’s core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo’s integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.

Gevo’s primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.